drugset / Trial / NCT00920296
DDI Study of Etravirine and GSK1265744
NaSingle-groupOpen-labelBasic science
Summary
The primary objective of this study is to compare steady-state plasma PK, safety and tolerability of GSK1265744 with and without etravirine
Timeline
- Start
- 2009-07
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cabotegravir | Small molecule | — | — |